These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5552459)

  • 21. Agranulocytosis during dapsone administration.
    Ten Broeke JE; Cunningham LD
    Dermatologica; 1973; 146(1):21-4. PubMed ID: 4694139
    [No Abstract]   [Full Text] [Related]  

  • 22. Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).
    Booth F; Barker LC; Barton CJ; Naik RB
    Postgrad Med J; 1984 Aug; 60(706):566-7. PubMed ID: 6473241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications.
    Satarasinghe RL; Jayawardana MA; De Silva GV; Murugathas S; Riyaaz AA; Wickrmasingha UD; Wijesinghe R
    Drug Metabol Drug Interact; 2009; 24(2-4):325-9. PubMed ID: 20408505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Agranulocytosis caused by dapsone in rheumatoid arthritis].
    Eulry F; Pattin S; Auzanneau G; Martoia R; Doury P
    Ann Med Interne (Paris); 1989; 140(1):55-6. PubMed ID: 2735638
    [No Abstract]   [Full Text] [Related]  

  • 25. Asymptomatic dapsone-induced agranulocytosis in a patient with chronic spontaneous urticaria.
    Milkova L; Hallermann C; Simon JC; Treudler R
    J Dtsch Dermatol Ges; 2014 Aug; 12(8):717-9. PubMed ID: 24981604
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant granulocyte colony-stimulating factor for dapsone-induced agranulocytosis in leukocytoclastic vasculitis.
    Miyagawa S; Shiomi Y; Fukumoto T; Ishii Y; Shirai T
    J Am Acad Dermatol; 1993 Apr; 28(4):659-61. PubMed ID: 7681858
    [No Abstract]   [Full Text] [Related]  

  • 27. Dapsone-associated agranulocytosis and severe anemia in a patient with leukocytoclastic vasculitis.
    Woodbury GR; Fried W; Ertle JO; Malkinson FD
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):781-3. PubMed ID: 8496428
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dapsone-induced agranulocytosis. The role of xenobiotic-metabolizing enzymes demonstrated by a case report].
    Hoffmann TK; von Schmiedeberg S; Wulferink M; Thier R; Bier H; Ruzicka T; Lehmann P
    Hautarzt; 2005 Jul; 56(7):673-7. PubMed ID: 15999287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferation of IgD kappa plasma cells after agranulocytosis induced by dapsone.
    Lahuerta-Palacios JJ; Gomez-Pedraja JF; Montalban MA; Shandas GJ; Gomez-Salazar MD
    Br Med J (Clin Res Ed); 1985 Jan; 290(6464):282-3. PubMed ID: 3917786
    [No Abstract]   [Full Text] [Related]  

  • 30. Dapsone-induced agranulocytosis in patients with Hansen's disease.
    Fernandes TRMO; Jesus BN; Barreto TT; Pereira AA
    An Bras Dermatol; 2017; 92(6):894-897. PubMed ID: 29364462
    [No Abstract]   [Full Text] [Related]  

  • 31. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR; Mendis S; Weerakoon HS
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agranulocytosis during multidrug therapy (MDT) of leprosy.
    Reeve P
    Lepr Rev; 1992 Mar; 63(1):82-3. PubMed ID: 1569822
    [No Abstract]   [Full Text] [Related]  

  • 33. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention.
    Coleman MD
    Toxicology; 2001 Apr; 162(1):53-60. PubMed ID: 11311458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agranulocytosis associated with Maloprim.
    Bruce-Chwatt LJ; Hutchinson DB
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65-6. PubMed ID: 6418319
    [No Abstract]   [Full Text] [Related]  

  • 35. Maloprim and agranulocytosis.
    Bruce-Chwatt LJ; Hutchinson DB
    Lancet; 1983 Dec 24-31; 2(8365-66):1487-8. PubMed ID: 6140569
    [No Abstract]   [Full Text] [Related]  

  • 36. Reactions to dapsone.
    Lancet; 1981 Sep; 2(8246):585. PubMed ID: 6116030
    [No Abstract]   [Full Text] [Related]  

  • 37. Maloprim-induced agranulocytosis and red-cell aplasia.
    Nicholls MD; Concannon AJ
    Med J Aust; 1982 Dec 11-25; 2(12):564-6. PubMed ID: 7162443
    [No Abstract]   [Full Text] [Related]  

  • 38. Antithyroid drug-induced agranulocytosis complicated by pneumococcal sepsis and upper airway obstruction.
    Ishimaru N; Ohnishi H; Nishiuma T; Doukuni R; Umezawa K; Oozone S; Kuramoto E; Yoshimura S; Kinami S
    Intern Med; 2013; 52(20):2355-9. PubMed ID: 24126400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agranulocytosis associated with Maloprim.
    Br Med J (Clin Res Ed); 1983 May; 286(6376):1515. PubMed ID: 6405867
    [No Abstract]   [Full Text] [Related]  

  • 40. Agranulocytosis associated with malaria prophylaxis with Maloprim.
    Friman G; Nyström-Rosander C; Jonsell G; Björkman A; Lekås G; Svendsrup B
    Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1244-5. PubMed ID: 6404407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.